Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) traded at $511.92 at close of the session on Monday, June 23 and made an upward move of 0.43%% on its previous day’s price. Looking at the stock we see that its previous close was $509.72 and the beta (5Y monthly)
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) shares, rose in value, with the stock price down by -1.22% to the previous day’s close as strong demand from buyers drove the stock to $507.33. Actively observing the price movement in the recent trading, the stock is buoying the session
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) price closed higher on Friday, June 06, and jumping 2.10% above its previous close. A look at the daily price movement shows that the last close reads $483.07. The company’s P/E ratio in the trailing 12-month period read 12.55. Taking into
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) concluded the trading at $484.93 on Wednesday, June 04 with a fall of -0.60% from its closing price on previous day. Company’s P/E ratio for the trailing 12 months is 12.34. Considering stock’s 52-week price range provides that REGN hit a
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) traded at $490.28 at close of the session on Friday, May 30 and made a downward move of -19.01% on its previous day’s price. Regeneron Pharmaceuticals, Inc has a market cap of $52.93 billion and is expected to release its quarterly
In the biotechnology industry, companies produce drugs that treat illness and diagnostic technologies. For these products to be approved by the FDA, the process is lengthy and expensive. Food and Drug Administration (FDA). In this case, investors may have to wait years to find out
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.